Akute Immunneuropathie und Optikusneuritis – Übersicht und Fallbericht eines seltenen Überlappungssyndroms

Zusammenfassung

Die vorliegende Arbeit gibt einen Überblick über nosologische, pathomechanistische und therapeutische Aspekte von kranialen Überlappungssyndromen akuter Immunneuropathien. Eine 18-jährige Patientin entwickelte eine bilaterale faziale Parese, akrodistale Parästhesien und Sehstörungen nach einem gastrointestinalen Infekt. Kraft, Koordination und Muskeleigenreflexe der Extremitäten waren regelrecht. Bei Kontrastmittelaufnahme mehrerer Hirnnerven sowie von Konus- und Kaudafasern, zytoalbuminärer Dissoziation im Liquor und Demyelinisierungszeichen in der Elektroneurographie diagnostizierten wir eine akut-inflammatorische demyelinisierende Polyradikuloneuritis mit Neuritis nervi optici. Die Beschwerden der Patientin sprachen gut auf eine Plasmapherese an. Auch bei Patienten mit Hirnnervenparesen und Parästhesien ohne Hyporeflexie oder Extremitätenschwäche sollte an eine akute Immunneuropathie gedacht werden. Kombinationen mit zentraler Affektion wie der Optikusneuritis sind dabei möglich.

Abstract

The present work provides an overview of nosological, pathomechanistic and therapeutic aspects of cranial overlap syndromes of acute immune-mediated neuropathies. An 18-year-old woman developed bilateral facial palsy and hypesthesia, acrodistal paresthesia as well as impaired vision after a gastrointestinal infection. Muscle power and coordination were unaffected and deep tendon reflexes were preserved. Based on contrast enhancement of cranial nerves II, IV, V and VII as well as conus and cauda fibers, albuminocytologic dissociation in the cerebrospinal fluid and electroneurographic signs of demyelination, we diagnosed acute-inflammatory demyelinating polyradiculoneuropathy with optic neuritis. The patient’s complaints responded well to plasmapheresis. Even in patients with cranial nerve palsies and paresthesias without diminished deep tendon reflexes or extremity weakness, one should consider the possibility of acute immune-mediated neuropathy. A coincident central affection such as optic neuritis is possible.

Schlüsselwörter

Inflammatorische Neuropathie - Diplegia facialis - Parästhesie - Polyneuritis cranialis - Zytoalbuminäre Dissoziation

Keywords

Inflammatory neuropathy - paresthesia - albuminocytologic dissociation - bifacial weakness - polyneuritis cranialis

Publication History

Article published online:
02 July 2024

• Literatur

• 1 Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome. Lancet 2021; 397: 1214-1228
• 2 Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes. Pract Neurol 2015; 15: 90-99
• 3 Wakerley BR, Uncini A, Yuki N. et al. Guillain-Barre and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol 2014; 10: 537-544
• 4 Wakerley BR, Yuki N. Polyneuritis cranialis--subtype of Guillain-Barre syndrome?. Nat Rev Neurol 2015; 11: 664
• 5 Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barre syndrome. J Neurol 2015; 262: 2001-2012
• 6 Susuki K, Koga M, Hirata K. et al. A Guillain-Barre syndrome variant with prominent facial diplegia. J Neurol 2009; 256: 1899-1905
• 7 Stuby J, Roth R, Strecker N. et al. Post-COVID-19 bifacial weakness and paraesthesia: a case report. Swiss Med Wkly 2021; 151: w30066
• 8 Hutchins KL, Jansen JH, Comer AD. et al. COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barre Syndrome. AJNR Am J Neuroradiol 2020; 41: 1707-1711
• 9 Castiglione JI, Crespo JM, Lecchini L. et al. Bilateral facial palsy with paresthesias, variant of Guillain-Barre syndrome following COVID-19 vaccine: A case series of 9 patients. Neuromuscul Disord 2022; 32: 572-574
• 10 Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37
• 11 Baxter R, Lewis E, Fireman B. et al. Case-centered Analysis of Optic Neuritis After Vaccines. Clin Infect Dis 2016; 63: 79-81
• 12 Petzold A, Fraser CL, Abegg M. et al. Diagnosis and classification of optic neuritis. Lancet Neurol 2022; 21: 1120-1134
• 13 Li H, Li Z, Huang B. et al. Co-occurrence of polyneuritis crainials and visual impairment: a case report and literature review. Neurol Sci 2022; 1-12
• 14 Richardson-May J, Purcaru E, Campbell C. et al. Guillain-Barre Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review. Neuroophthalmology 2022; 46: 413-419
• 15 Rubino A, Della Corte M, Bruno G. et al. Atypical Clinical and Neuroradiological Findings in a Child With Bifacial Weakness With Paresthesias. J Clin Neuromuscul Dis 2021; 23: 105-109
• 16 Doxaki C, Papadopoulou E, Maniadaki I. et al. Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome. Front Pediatr 2020; 8: 608695
• 17 Chen A, Kim J, Henderson G. et al. Posterior reversible encephalopathy syndrome in Guillain-Barre syndrome. J Clin Neurosci 2015; 22: 914-916
• 18 Nadkarni N, Lisak RP. Guillain-Barre syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology 1993; 43: 842-843
• 19 Chan JW. Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol 2003; 87: 1185-1186
• 20 Andersen EW, Ryan MM, Leventer RJ. Guillain-Barre syndrome with optic neuritis. J Paediatr Child Health 2022; 58: 887-890
• 21 Wakerley BR, Kokubun N, Funakoshi K. et al. Clinical classification of 103 Japanese patients with Guillain-Barre syndrome. J Neurol Sci 2016; 369: 43-47
• 22 Hiew FL, Ramlan R, Viswanathan S. et al. Guillain-Barre Syndrome, variants & forms fruste: Reclassification with new criteria. Clin Neurol Neurosurg 2017; 158: 114-118
• 23 Kumar P, Charaniya R, Bahl A. et al. Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome. J Clin Diagn Res 2016; 10: OD01-OD02
• 24 Trikamji B, Adler M. Guillain-Barre Syndrome Variant With Facial Diplegia and Paresthesias Presenting With Bulbar Weakness. J Clin Neuromuscul Dis 2019; 21: 122-123
• 25 Kim JK, Oh SY, Sohn EH. et al. When is facial diplegia regarded as a variant of Guillain-Barre syndrome?. J Peripher Nerv Syst 2015; 20: 32-36
• 26 Frahm-Falkenberg S, de la Cour CD, Andersen PB. Simultaneous bilateral peripheral facial paralysis is a rare variant of Guillain-Barre syndrome. Ugeskr Laeger 2014; 176 V01140028
• 27 Albuainain G. Bilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barre Syndrome. Am J Case Rep 2021; 22: e932757
• 28 Dal Verme A, Acosta P, Margan M. et al. Facial diplegia with atypical paresthesia. A variant of Guillain-Barre syndrome. Medicina (B Aires) 2015; 75: 178-180
• 29 Susuki K, Atsumi M, Koga M. et al. Acute facial diplegia and hyperreflexia: A Guillain-Barre syndrome variant. Neurology 2004; 62: 825-827
• 30 Lehmann HC, Macht S, Jander S. et al. Guillain-Barre syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes. J Neurol 2012; 259: 370-371
• 31 Yuki N, Kokubun N, Kuwabara S. et al. Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes. J Neurol 2012; 259: 1181-1190
• 32 Aasfara J, Hajjij A, Bensouda H. et al. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report. Pan Afr Med J 2021; 38: 30
• 33 Carroll CG, Campbell WW. Multiple cranial neuropathies. Semin Neurol 2009; 29: 53-65
• 34 Götz GF, Hartmann H, Giesemann AM. Polyneuritis cranialis: Neuroborreliose mit asymptomatischem Hirnnervenenhancement. Klinische Neurophysiologie 2015; 46: 98-99
• 35 Achenbach P, Block F, Dafotakis M. Medikamentös-induzierte Polyneuropathien jenseits von Chemotherapeutika und Antiinfektiva. Klinische Neurophysiologie 2022; 53: 174-187
• 36 Yamashita H, Koga M, Morimatsu M. et al. Polyneuritis cranialis related to anti-GT1 a IgG antibody. J Neurol 2001; 248: 65-66
• 37 Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 2013; 84: 576-583
• 38 Koga M, Yoshino H, Morimatsu M. et al. Anti-GT1a IgG in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2002; 72: 767-771
• 39 O'Leary CP, Veitch J, Durward WF. et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996; 61: 649-651
• 40 Yoshino H, Maeda Y, King M. et al. Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of humans. Neurology 1993; 43: 408-411
• 41 Chiba A, Kusunoki S, Obata H. et al. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997; 745: 32-36
• 42 Biotti D, Boucher S, Ong E. et al. Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome. J Neurol 2013; 260: 2890-2891
• 43 Lamotte G, Laballe R, Dupuy B. Bilateral eyelid retraction, loss of vision, ophthalmoplegia: an atypical triad in anti-GQ1b syndrome. Rev Neurol (Paris) 2014; 170: 469-470
• 44 Incecik F, Herguner OM, Besen S. et al. Guillain-Barre syndrome with hyperreflexia and bilateral papillitis in a child. J Pediatr Neurosci 2016; 11: 71-73
• 45 Wen HJ. Acute bilateral vision deficit as the initial symptom in Guillain-Barre syndrome: A case report. Exp Ther Med 2018; 16: 2712-2716
• 46 Matsunaga M, Kodama Y, Maruyama S. et al. Guillain-Barre syndrome and optic neuritis after Mycoplasma pneumoniae infection. Brain Dev 2018; 40: 439-442
• 47 Cortese A, Franciotta D, Alfonsi E. et al. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment. J Neurol Sci 2016; 363: 182-187
• 48 Kamm C. New clinical insights into combined central and peripheral demyelination (CCPD). J Neurol Sci 2016; 364: 27-28
• 49 Kira JI. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism. Front Neurol 2021; 12: 665136
• 50 Hughes RA, Brassington R, Gunn AA. et al. Corticosteroids for Guillain-Barre syndrome. Cochrane Database Syst Rev 2016; 10: CD001446
• 51 Biotti D, Vignal C, Sharshar T. et al. Blindness, weakness, and tingling. Surv Ophthalmol 2012; 57: 565-572
• 52 Belkhribchia MR, Chekabab A, Naji Y. et al. Severe Headache, Paraesthesias, Facial Diplegia and Pleocytosis: A Misleading Presentation of Guillain-Barre Syndrome. Eur J Case Rep Intern Med 2021; 8: 002211